Announcement of the progress of Wuhan Keqian Biology Co., Ltd. on the repurchase of shares through centralized bidding
Announcement of Wuhan Keqian Biology Co., Ltd. on the first repurchase of the company's shares through centralized bidding transactions
Report on the repurchase of Wuhan Keqian Biology Co., Ltd. on the repurchase of the company's shares through centralized bidding transactions
Announcement of Wuhan Keqian Biology Co., Ltd. on the actual controller of the company proposed to buy back the company\'s shares and the company\'s “improve quality, increase efficiency and value return” action plan
Announcement of Wuhan Keqian Biotech Co., Ltd. on some shareholders holding 5% or more of the shares promised not to reduce their holdings of the company during a specific period
Wuhan Keqian Biology Co., Ltd. Simplified Equity Change Report (1)
Wuhan Keqian Biology Co., Ltd. Simplified Equity Change Report (2)
Announcement on the listing and circulation of restricted shares in the initial public offering of Wuhan Keqian Biotech Co., Ltd.
Some senior managers of Wuhan Keqian Biotech Co., Ltd. announced the results of centralized bidding to reduce holdings without reducing their holdings at the end of the plan period
Wuhan Keqian Biology Co., Ltd.\'s 2021 Restricted Stock Incentive Plan Part I Restricted Stock Repurchase Cancellation Implementation Notice
Legal Opinion of Beijing Jiayuan Law Firm on the Implementation of the Cancellation of Class I Restricted Stock Repurchase Part of the 2021 Restricted Stock Incentive Plan of Wuhan Keqian Biology Co., Ltd.
Announcement of Wuhan Keqian Biology Co., Ltd. on receiving the “Decision on Terminating the Review of the Issuance of Shares by Wuhan Keqian Biology Co., Ltd. to Specific Targets” from the Shanghai Stock Exchange
Announcement of Wuhan Keqian Biotech Co., Ltd. on withdrawing the application documents for issuing A-shares to specific targets in 2022
Wuhan Keqian Biology Co., Ltd. 2022 Annual Equity Distribution Implementation Notice
Announcement on the progress of some senior managers of Wuhan Keqian Biology Co., Ltd. concentrating on bidding to reduce their stock holdings
Supplementary legal opinion of Beijing Jiayuan Law Firm on the issuance of A-shares to specific targets by Wuhan Keqian Biology Co., Ltd. in 2022 (1)
Wuhan Keqian Biotech Co., Ltd. issued A-share prospectus to specific targets (report draft) (updated version of financial data for the first quarter of 2023)
Announcement of Wuhan Keqian Biotech Co., Ltd. to notify creditors of the repurchase and cancellation of some Class I restricted stocks
Letter of sponsorship from China Merchants Securities Co., Ltd. relating to the issuance of shares by Wuhan Keqian Biotech Co., Ltd. to specific targets (updated version of financial data for the first quarter of 2023)
China Merchants Securities Co., Ltd.\'s listing sponsorship letter for the issuance of shares by Wuhan Keqian Biotech Co., Ltd. to specific targets (updated version of financial data for the first quarter of 2023)
No Data